Sage Journals: Discover world-class research

Free access

Case report

First published 2025-1

A case of autoimmune hepatitis associated with the PCSK9 inhibitor alirocumab

Amira Ibrahim, Geeta Prasad, Eric S Kilpatrick [...]

Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Open access

Research article

First published 2018

Alirocumab in the management of primary hypercholesterolaemia or mixed dyslipidaemia: A budget impact analysis – Italian perspective

Alessia Marocco, Sanja Stanisic, Francesca Fanelli [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Retricted access

Review article

First published 2015-12

Therapeutic Potential and Critical Analysis of the PCSK9 Monoclonal Antibodies Evolocumab and Alirocumab

C. Michael White

Annals of Pharmacotherapy

Open access

Research article

First published 2020

Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies

Tahir Mahmood, Jessica Minnier, Matthew K Ito [...]

European Journal of Preventive Cardiology

Open access

Letter

First published 2018-4

RE: Praluent (Alirocumab)-Induced Renal Injury

Robert S. Rosenson, Dominique Larrey, David D. Waters [...]

Journal of Pharmacy Practice

Open access

Research article

First published 2020-10

Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab

Antonio J Vallejo-Vaz, Lawrence A Leiter, Stefano Del Prato [...]

European Journal of Preventive Cardiology

Free access

Review article

First published 2018-7

Alirocumab as add-on therapy to statins: current evidence and clinical potential

Johann Auer, Robert Berent

Therapeutic Advances in Cardiovascular Disease

Open access

Research article

First published 2017

A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics

Jeffrey E Ming, Ruth E Abrams, Derek W Bartlett [...]

Gene Regulation and Systems Biology

Open access

Case report

First published 2019

Fatal Recurrent Staphylococcus aureus Infection in a Patient With an Aortic Endostent Under Alirocumab

Claudia Stöllberger, Gerard Mertikian, Dorit Stahl [...]

Infectious Diseases: Research and Treatment

Open access

Research article

First published 2020

Intensity of statin treatment after acute coronary syndrome,residual risk,and its modification by alirocumab: insights from the ODYSSEY OUTCOMES trial

Rafael Diaz, Qian H Li, Deepak L Bhatt [...]

European Journal of Preventive Cardiology

Search results